Biomm
Blood & Organ Banks · Brazil · 51-200 Employees
View Company Info for Free
Overview
Headquarters
705 Avenida Regent, Nova Lima, Minas Ger...Phone Number
+55 3132991000Website
www.biomm.comRevenue
$20 MillionIndustry
About Biomm
Biomm Org Chart
Is Biomm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Biomm launches new products
Website visits: Recent activity has been detected on your website
Check if Biomm has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Biomm had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Biomm has new funding data
Biomm, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Biomm
Check out if Biomm is spiking on competitors!
Earning: See what the market has to say on Biomm recently announced quarterly report
Recommended Actions
Find VP level buyers at Biomm
Find 3 more new buyers
Company Profile Activity
Activity Insights
Biomm is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Biomm is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Biomm.
Biomm Tech Stack
A closer look at the technologies used by Biomm
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biomm
Biomm is a pioneering biotechnology company in Brazil that develops innovative biopharmaceuticals aimed at transforming lives and advancing science. The company focuses on providing health solutions for individuals with chronic diseases, enhancing their access to high-tech treatments. Biomm is committed to increasing Brazil's autonomy in the pharma... Read More